highly significantp<0.001
Plasma sLOX-1 levels showed a strong discrimination among healthy and NSTMI patients (AUC 0.916) ( Figure-3A ) and also between healthy subjects with STEMI patients (AUC 0.925) ( Figure-3B ) and they were statistically highly significant (p<0.001).